Here's Eddie Murphy With All 10 of His Kids — for the First Time

Who’s your daddy? If you’re not sure, you might want to check with Eddie Murphy. The comedy legend, 57, has 10 kids — all of whom appear with him in a holiday photo posted by his daughter Bria Murphy on her Instagram. It’s the family’s very first photo all together. Check out this posse: View this post on Instagram Merry […]

Read more

Higher average potency cannabis may increase risk for first disorder symptom

Recreational cannabis is legal in 10 states and Washington, D.C., but regulations regarding potency do not exist. The results of a new study, led by an Iowa State University researcher, may prompt states to reconsider. Higher average potency cannabis at first use increases the risk for the first symptom of cannabis use disorder within a year of use, according to […]

Read more

Baby’s first cold can last longer depending on nose-dwelling bacteria

New research on the types of bacteria living in babies’ noses could offer clues as to why some recover quickly from their first cough or cold, while others suffer for longer. The study, published in ERJ Open Research, suggests that babies who have a wide variety of different bacteria living in their noses tend to recover more quickly from their […]

Read more

FDA Approves First Biosimilar to Non-Hodgkin’s Lymphoma Drug

WEDNESDAY, Nov. 28, 2018 — Truxima (rituximab-abbs) has been approved by the U.S. Food and Drug Administration as the first biosimilar to the non-Hodgkin’s lymphoma drug Rituxan, the agency said today. Truxima, as with Rituxan, is approved to treat adults with CD20-positive, B-cell non-Hodgkin’s lymphoma to be used as a single agent or in combination with chemotherapy. The most common […]

Read more

Gene vital for post-stroke recovery identified for the first time

Having certain specific variants of the PATJ gene predisposes ischemic stroke victims for worse recovery. Seven out of 10 patients with these variants suffer severe sequelae three months after having a stroke and are thus placed in a situation of medical dependence, compared to less than half of patients who do not present these variants. This is according to data […]

Read more

Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients

NEW YORK & INDIANAPOLIS–(BUSINESS WIRE October 23, 2018 )–Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, in patients with osteoarthritis (OA) pain treated for 16 weeks. The study met all three co-primary efficacy endpoints, demonstrating […]

Read more